News About: R&D


11,800 million won of government subsidy on drug R&D.

The MOHW reported "2000 health, medical technology research and development implementation project" on March 10, which included 1) 11,790 million won for the drug R&D, 2) 3,670 million won for the medical science 3) 3...

Functional cosmetics allowed to label its efficacy and indications.

To prepare the implementation of the cosmetic law taking effect from the upcoming July 1, the MOHW drafted the working rules and enforcement decree of the cosmetic law, allowing active ingredients, efficacies, indicat...

Domestic companies to rush in bioengineering industry.

Having assessed the bio-engineering industry as a super high technological and value added areas, many domestic enterprises including pharmaceutical manufacturers tried to make an investment rush. Korea Industrial Re...

Domestic drug companies rush in Cisapride development.

Local drug companies rushed in a market search of Cisapride (Brand name: Prepulcid), a gastric motility enhancer, originally developed by Janssen, who has enjoyed the market with this product since long time but now e...

Stock prices of pharmaceutical industry sensitively moved by new drug development.

Overall stock prices of pharmaceutical industries last year showed an ultimate bipolar phenomenon in the bourse with a great wave of fluctuation, manifesting comparatively higher figures with the R&D oriented pharmace...

Law pertaining to new drug R&D promotion from natural resources.

The National Assembly enacted the law pertaining to new drug R&D promotion from natural resources to make a bridgehead for advancing the domestic drug industry in the 21st century. The law jointly raised by 13 ruling...

Revised criteria on drug revaluation announced to be legislated

The KFDA announced to legislate "Revised bill for drug revaluation standard" on Nov. 12 for the purpose of supplementing problems and shortcomings as resulted from revaluation and examination of the product on subject...

Uniformity in number of patients for clinical test to be modified.

The new drug re-evaluation system implemented from 1995 has to be reasonably readjusted in its provisional requirement of tested patient numbers that should be varied by different preparations in consideration with ea...

Development of intermediary compounds for 4th generation antibiotics in progress.

Daewoong Chemical (President: Mr. Moon Soon-ku) has succeeded in developing the key intermediary compounds (DW-1150) for the new 4th generation of Phenem and Carbaphenem antibiotics, The core technology of the i...

1,500 billion won subsidy for new drug R&D by 2010.

The MOHW announced in the meeting of the parliamentary inspection of the government administration that 1,500 billion won of financial subsidy would be provided for the R&D of new drug discovery by year 2010 especial...

Most Read News


April
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
SunMonTueWedThuFriSat
30
31
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
1
2
3
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.